JANX
Janux Therapeutics, Inc. NASDAQ Listed Jun 11, 2021$14.34
+0.84%
vs $14.22
Mkt Cap $888.6M
52w Low $12.18
9.6% of range
52w High $34.74
50d MA $14.40
200d MA $18.00
P/E (TTM)
-7.8x
EV/EBITDA
—
P/B
0.9x
Debt/Equity
0.0x
ROE
-11.9%
P/FCF
-10.7x
RSI (14)
49.00
ATR (14)
$0.56
Beta
2.81
50d MA
$14.40
200d MA
$18.00
Avg Volume
934.0K
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.
11099 North Torrey Pines Road · San Diego, CA 92037 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.52 | -0.39 | +25.0% | 14.54 | -0.7% | -2.5% | +0.4% | +1.3% | +1.4% | -1.5% | — |
| Feb 26, 2026 | AMC | -0.65 | -0.51 | +21.5% | 13.80 | -1.6% | -1.4% | -1.4% | +0.1% | +6.8% | -2.6% | — |
| Nov 6, 2025 | AMC | -0.60 | -0.39 | +35.0% | 28.66 | +1.7% | -7.6% | +4.2% | +4.6% | -1.2% | -3.7% | — |
| Aug 7, 2025 | AMC | -0.48 | -0.55 | -14.6% | 22.58 | -1.5% | +1.1% | -0.7% | +7.1% | +2.8% | +0.0% | — |
| May 8, 2025 | AMC | -0.43 | -0.38 | +11.6% | 26.37 | -0.5% | -3.1% | +2.0% | -2.8% | -10.7% | +2.9% | — |
| Feb 27, 2025 | AMC | -0.49 | -0.36 | +26.5% | 32.01 | +1.1% | +2.7% | -3.2% | -5.8% | +5.0% | -2.4% | — |
| Nov 6, 2024 | AMC | -0.37 | -0.51 | -37.8% | 54.89 | +1.9% | -1.2% | -0.5% | -0.4% | -1.6% | -1.6% | — |
| Aug 7, 2024 | AMC | -0.32 | -0.11 | +65.6% | 35.29 | +1.1% | +3.4% | -1.7% | +2.1% | +4.1% | +5.4% | — |
| May 7, 2024 | AMC | -0.35 | -0.30 | +14.3% | 61.50 | -12.7% | -10.0% | -6.2% | -5.8% | +2.2% | -4.2% | — |
| Mar 8, 2024 | AMC | -0.37 | -0.25 | +32.4% | 39.81 | +5.5% | +0.4% | -2.9% | +2.8% | -5.4% | +4.4% | — |
| Nov 7, 2023 | AMC | -0.46 | -0.25 | +45.7% | 6.56 | +2.3% | +0.9% | -11.6% | +3.2% | +17.4% | +17.5% | — |
| Aug 8, 2023 | AMC | -0.52 | -0.42 | +19.2% | 11.87 | +0.8% | +6.8% | -0.7% | -0.1% | -0.4% | -4.2% | — |
| May 9, 2023 | AMC | -0.49 | -0.42 | +14.3% | 13.32 | +1.6% | +4.1% | -6.1% | -2.0% | -5.6% | -4.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | Jones Trading | Maintains | Buy → Buy | — | $15.23 | $15.12 | -0.7% | -4.8% | -2.7% | +1.8% | -0.2% | +0.6% |
| Apr 20 | Barclays | Downgrade | Overweight → Underweight | — | $15.82 | $14.93 | -5.6% | +0.3% | -2.6% | -0.5% | -1.3% | -1.2% |
| Apr 15 | UBS | Downgrade | Buy → Neutral | — | $15.24 | $14.68 | -3.7% | -1.3% | +1.0% | +4.1% | +0.3% | -2.6% |
| Feb 27 | Guggenheim | Maintains | Buy → Buy | — | $13.80 | $13.58 | -1.6% | -1.4% | -1.4% | +0.1% | +6.8% | -2.6% |
| Feb 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $13.80 | $13.58 | -1.6% | -1.4% | -1.4% | +0.1% | +6.8% | -2.6% |
| Jan 20 | Clear Street | Downgrade | Buy → Hold | — | $13.76 | $13.11 | -4.7% | -4.4% | +0.9% | +14.1% | -2.2% | -1.1% |
| Jan 16 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.72 | $13.67 | -0.4% | +0.3% | -4.4% | +0.9% | +14.1% | -2.2% |
| Dec 17 | Barclays | Maintains | Overweight → Overweight | — | $14.65 | $14.61 | -0.3% | -3.8% | -0.4% | -1.8% | +2.2% | +0.2% |
| Dec 2 | Clear Street | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | +7.9% | -4.1% | +0.7% | +0.4% |
| Dec 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | +7.9% | -4.1% | +0.7% | +0.4% |
| Dec 2 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $33.99 | $18.51 | -45.5% | -53.3% | +7.9% | -4.1% | +0.7% | +0.4% |
| Dec 2 | BofA Securities | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | +7.9% | -4.1% | +0.7% | +0.4% |
| Dec 2 | Stifel | Maintains | Buy → Buy | — | $33.99 | $18.51 | -45.5% | -53.3% | +7.9% | -4.1% | +0.7% | +0.4% |
| Nov 25 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $31.53 | $32.19 | +2.1% | +10.2% | -0.1% | -1.7% | -0.3% | -53.3% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $28.66 | $29.14 | +1.7% | -7.6% | +4.2% | +4.6% | -1.2% | -3.7% |
| Mar 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $32.89 | $32.53 | -1.1% | -3.2% | -5.8% | +5.0% | -2.4% | -0.4% |
| Feb 28 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $32.01 | $32.37 | +1.1% | +2.7% | -3.2% | -5.8% | +5.0% | -2.4% |
| Dec 11 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $62.36 | $62.44 | +0.1% | +1.7% | -3.1% | -0.6% | +0.7% | -3.2% |
| Dec 4 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $59.86 | $60.00 | +0.2% | +11.6% | -0.8% | -2.0% | -5.1% | +1.2% |
| Dec 3 | Stifel | Maintains | Buy → Buy | — | $40.18 | $67.17 | +67.2% | +49.0% | +11.6% | -0.8% | -2.0% | -5.1% |
| Dec 3 | Leerink Partners | Maintains | Outperform → Outperform | — | $40.18 | $67.17 | +67.2% | +49.0% | +11.6% | -0.8% | -2.0% | -5.1% |
| Dec 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $40.18 | $67.17 | +67.2% | +49.0% | +11.6% | -0.8% | -2.0% | -5.1% |
| Nov 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $54.89 | $55.91 | +1.9% | -1.2% | -0.5% | -0.4% | -1.6% | -1.6% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $54.89 | $55.91 | +1.9% | -1.2% | -0.5% | -0.4% | -1.6% | -1.6% |
| Sep 16 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $50.01 | $50.39 | +0.8% | -0.2% | -0.9% | -2.3% | +3.4% | +0.4% |
| Aug 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $41.32 | $41.22 | -0.2% | +5.1% | +3.5% | -0.0% | -1.6% | +3.9% |
| Aug 9 | Scotiabank | Maintains | Sector Perform → Sector Perform | — | $36.49 | $36.19 | -0.8% | -1.7% | +2.1% | +4.1% | +5.4% | +3.4% |
| Aug 8 | Wedbush | Maintains | Outperform → Outperform | — | $35.29 | $35.68 | +1.1% | +3.4% | -1.7% | +2.1% | +4.1% | +5.4% |
| Aug 8 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $35.29 | $35.68 | +1.1% | +3.4% | -1.7% | +2.1% | +4.1% | +5.4% |
| May 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $48.92 | $50.00 | +2.2% | +2.2% | -4.2% | -0.9% | +0.1% | -0.9% |
| May 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $55.37 | $54.00 | -2.5% | -6.2% | -5.8% | +2.2% | -4.2% | -0.9% |
| May 8 | Wedbush | Maintains | Outperform → Outperform | — | $61.50 | $53.68 | -12.7% | -10.0% | -6.2% | -5.8% | +2.2% | -4.2% |
| Mar 13 | BofA Securities | Maintains | Buy → Buy | — | $38.83 | $39.45 | +1.6% | +2.8% | -5.4% | +4.4% | -1.6% | -0.5% |
| Mar 11 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $39.81 | $41.98 | +5.5% | +0.4% | -2.9% | +2.8% | -5.4% | +4.4% |
| Feb 27 | Wedbush | Maintains | Outperform → Outperform | — | $15.10 | $35.79 | +137.0% | +229.5% | -6.3% | +3.8% | -1.5% | -10.6% |
| Nov 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $6.04 | $6.04 | +0.0% | +17.4% | +17.5% | +5.4% | +0.5% | -1.6% |
| Nov 8 | Wedbush | Maintains | Outperform → Outperform | — | $6.56 | $6.71 | +2.3% | +0.9% | -11.6% | +3.2% | +17.4% | +17.5% |
| Aug 10 | Wedbush | Maintains | Outperform → Outperform | — | $12.68 | $12.74 | +0.5% | -0.7% | -0.1% | -0.4% | -4.2% | -6.8% |
| Aug 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $11.87 | $11.96 | +0.8% | +6.8% | -0.7% | -0.1% | -0.4% | -4.2% |
| Jul 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.12 | $12.12 | +0.0% | +3.1% | +1.6% | -1.7% | +2.6% | +6.6% |
| Jul 18 | Wedbush | Maintains | Outperform → Outperform | — | $12.12 | $12.12 | +0.0% | +3.1% | +1.6% | -1.7% | +2.6% | +6.6% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.32 | $13.53 | +1.6% | +4.1% | -6.1% | -2.0% | -5.6% | -4.2% |
| May 10 | Wedbush | Maintains | Outperform → Outperform | — | $13.32 | $13.53 | +1.6% | +4.1% | -6.1% | -2.0% | -5.6% | -4.2% |
| Apr 6 | Wedbush | Maintains | Outperform → Outperform | — | $12.20 | $12.35 | +1.2% | +10.0% | +0.7% | +3.0% | +1.1% | +6.5% |
| Mar 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.09 | $14.09 | +0.0% | -2.3% | +4.4% | -6.3% | -1.6% | -9.9% |
| Nov 14 | William Blair | Maintains | Outperform → Outperform | — | $17.93 | $17.93 | +0.0% | -8.3% | +0.2% | -4.7% | +0.6% | -7.8% |
| Jul 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $25.40 | $25.50 | +0.4% | +2.7% | +4.6% | -1.6% | +3.5% | -4.0% |
| Jul 6 | TD Cowen | Maintains | Outperform → Outperform | — | $25.40 | $25.50 | +0.4% | +2.7% | +4.6% | -1.6% | +3.5% | -4.0% |
| Jul 6 | BofA Securities | Maintains | Buy → Buy | — | $25.40 | $25.50 | +0.4% | +2.7% | +4.6% | -1.6% | +3.5% | -4.0% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | Sell | 4,059 | $14.03 | $57K | 75,941 | -2.91% | +3.88% |
| May 11, 2026 | Dobek Maria | Vice President, Accounting | Sell | 2,038 | $14.17 | $29K | 32,270 | -1.51% | +4.27% |
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Janus Henderson Group Plc | 4,196,409 | $58M | New | Mar 2026 |
| 2 | Fmr Llc | 2,535,724 | $35M | Reduced | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,811,365 | $25M | New | Mar 2026 |
| 4 | Alyeska Investment Group, L.p. | 1,601,089 | $22M | Added | Mar 2026 |
| 5 | Vanguard Portfolio Management Llc | 1,290,256 | $18M | New | Mar 2026 |
| 6 | Morgan Stanley | 1,236,770 | $17M | Added | Dec 2025 |
| 7 | Point72 Asset Management | 1,156,140 | $16M | Added | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 801,646 | $11M | Added | Mar 2026 |
| 9 | Irenic Capital Management Lp | 765,804 | $11M | New | Mar 2026 |
| 10 | Woodline Partners Lp | 738,032 | $10M | Reduced | Mar 2026 |
| 11 | Jane Street Group, Llc | 540,233 | $7M | Added | Dec 2025 |
| 12 | Algert Global Llc | 443,397 | $6M | Added | Mar 2026 |
| 13 | Millennium Management | 386,810 | $5M | Added | Mar 2026 |
| 14 | Hrt Financial Lp | 366,699 | $5M | Added | Mar 2026 |
| 15 | Northern Trust Corp | 362,180 | $5M | Added | Mar 2026 |
| 16 | Citadel Advisors Llc | 352,177 | $5M | Reduced | Mar 2026 |
| 17 | Man Group Plc | 342,986 | $5M | Added | Mar 2026 |
| 18 | Adar1 Capital Management, Llc | 298,546 | $4M | New | Mar 2026 |
| 19 | Caption Management, Llc | 272,500 | $4M | Added | Dec 2025 |
| 20 | Pictet Asset Management Holding Sa | 272,251 | $4M | Reduced | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$888.6M
Enterprise Value
-$78.0M
P/E (TTM)
-7.79x
Forward P/E
—
PEG Ratio
-0.18x
P/B
0.93x
P/S
41.11x
P/FCF
-10.67x
EV/EBITDA
—
Shares Out
62.0M
Financials (TTM)
Revenue
$21.6M
Net Income
-$114.5M
EBITDA
-$112.4M
Free Cash Flow
-$83.3M
Op Cash Flow
-$82.2M
EPS Basic
$-1.83
EPS Diluted
$-1.84
EPS Forward
$-2.40
Gross Margin
54.1%
Op Margin
—
Net Margin
—
Balance Sheet
Total Assets
$1.01B
Total Liab.
$50.7M
Total Equity
$956.8M
Cash
$966.6M
LT Debt
$0
Book Value/Sh
$15.44
Debt/Equity
0.02x
Current Ratio
39.04
Quick Ratio
39.04
Returns & Growth
ROE
-11.9%
ROA
-11.3%
ROIC
-16.0%
Rev Growth YoY
-5.5%
EPS Growth YoY
-43.0%
Price Returns
2W
+1.4%
1M
+1.5%
3M
+7.2%
6M
-57.2%
12M
-38.7%
Technicals
52W High
$34.74
52W Low
$12.18
50d MA
$14.40
200d MA
$18.00
RSI (14)
49.00
ATR (14)
$0.56
Beta
2.81
Avg Volume
934K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$28.40
High
$45.00
Low
$14.00
Median
$30.00
Data updated apr 25, 2026 4:39pm
· Source: financialmodelingprep.com